Publication Cover
Inhalation Toxicology
International Forum for Respiratory Research
Volume 29, 2017 - Issue 12-14
772
Views
29
CrossRef citations to date
0
Altmetric
Review Article

Asbestos fiber length and its relation to disease risk

ORCID Icon, &
Pages 541-554 | Received 21 May 2017, Accepted 29 Aug 2017, Published online: 20 Feb 2018

References

  • Aalto M, Heppleston AG. (1984). Fibrogenesis by mineral fibres: an in-vitro study of the roles of the macrophage and fibre length. Br J Exp Pathol 65:91–9.
  • ACGIH. (1980). Asbestos. In: ACGIH (ed.) American Conference of Governmental Industrial Hygienists, Documentation of the Threshold Limit Values: For Chemical Substances in the Workroom Environment. 4th ed. Cincinnati, OH: American Conference of Governmental Industrial Hygienists, 27–30.
  • Adamson IY, Bakowska J, Bowden DH. (1993). Mesothelial cell proliferation after instillation of long or short asbestos fibers into mouse lung. Am J Pathol 142:1209–16.
  • Adamson IY, Bowden DH. (1987a). Response of mouse lung to crocidolite asbestos. 1. Minimal fibrotic reaction to short fibres. J Pathol 152:99–107.
  • Adamson IY, Bowden DH. (1987b). Response of mouse lung to crocidolite asbestos. 2. Pulmonary fibrosis after long fibres. J Pathol 152:109–17.
  • ATSDR. (2002). Expert Panel on Health Effects of Asbestos and Synthetic Vitreous Fibers (SVF): The Influence of Fiber Length. Premeeting Comments; 2002 Oct 29–30; New York, NY. Atlanta, GA: Agency for Toxic Substances and Disease Registry.
  • Barlow CA, Lievense L, Gross S, et al. (2013). The role of genotoxicity in asbestos-induced mesothelioma: an explanation for the differences in carcinogenic potential among fiber types. Inhal Toxicol 25:553–67.
  • Becklake MR, Case BW. (1994). Fiber burden and asbestos-related lung disease: determinants of dose–response relationships. Am J Respir Crit Care Med 150:1488–92.
  • Berman DW, Crump KS. (2003). Final draft: technical support document for a protocol to assess asbestos-related risk. EPA# 9345.4-06; October 2003. Washington, DC: U.S. Environmental Protection Agency, Office of Solid Waste and Emergency Response.
  • Berman DW, Crump KS. (2008a). A meta-analysis of asbestos-related cancer risk that addresses fiber size and mineral type. Crit Rev Toxicol 38(Suppl. 1): 49–73.
  • Berman DW, Crump KS. (2008b). Update of potency factors for asbestos-related lung cancer and mesothelioma. Crit Rev Toxicol 38(Suppl. 1): 1–47.
  • Berman DW, Crump KS, Chatfield EJ, et al. (1995). The sizes, shapes, and mineralogy of asbestos structures that induce lung tumors or mesothelioma in AF/HAN rats following inhalation. Risk Anal 15:181–95. Erratum in: Risk Anal 15:541.
  • Bernstein D, Dunnigan J, Hesterberg T, et al. (2013). Health risk of chrysotile revisited. Crit Rev Toxicol 43:154–83.
  • Bernstein DM, Hoskins JA. (2006). The health effects of chrysotile: current perspective based upon recent data. Regul Toxicol Pharmacol 45:252–64.
  • Berry G. (1999). Models for mesothelioma incidence following exposure to fibers in terms of timing and duration of exposure and the biopersistence of the fibers. Inhal Toxicol 11:111–30.
  • Brain JD, Knudson DE, Sorokin SP, Davis MA. (1976). Pulmonary distribution of particles given by intratracheal instillation or by aerosol inhalation. Environ Res 11:13–33.
  • Burger BF, Engelbrecht FM. (1970a). The biological effects of the international standard reference asbestos samples on the lungs of rats. South Afr J Lab Clin Med 16:1271–4.
  • Burger BF, Englebrecht FM. (1970b). The biological effects of long and short fibers of crocidolite and chrysolite a after intra pleural injection into rats. South Afr J Lab Clin Med 16:1268–70.
  • Churg A, Wiggs B. (1984). Fiber size and number in amphibole asbestos-induced mesothelioma. Am J Pathol 115:437–42.
  • Churg A, Wiggs B. (1986). Fiber size and number in workers exposed to processed chrysotile asbestos, chrysotile miners, and the general population. Am J Ind Med 9:143–52.
  • Churg A, Wiggs B. (1987). Types, numbers, sizes, and distribution of mineral particles in the lungs of urban male cigarette smokers. Environ Res 42:121–9.
  • Coin PG, Roggli VL, Brody AR. (1992). Deposition, clearance, and translocation of chrysotile asbestos from peripheral and central regions of the rat lung. Environ Res 58:97–116.
  • Cossette M, Delvaux P. (1979). Technical evaluation of chrysotile asbestos ore bodies. Short Course Mineral Techn Asbestos Determin 4:79–109.
  • Crapo JD, Barry BE, Brody AR, O'Neil JJ. (1980). Morphological, morphometric and X-ray microanalytical studies on lung tissue of rats exposed to chrysotile asbestos in inhalation chambres. IARC Sci Publ 30:273–83.
  • Davis JM. (1972). The fibrogenic effects of mineral dusts injected into the pleural cavity of mice. Br J Exp Pathol 53:190–201.
  • Davis JM, Addison J, Bolton RE, et al. (1985). Inhalation studies on the effects of tremolite and brucite dust in rats. Carcinogenesis 6:667–74.
  • Davis JM, Addison J, Bolton RE, et al. (1986a). Inhalation and injection studies in rats using dust samples from chrysotile asbestos prepared by a wet dispersion process. Br J Exp Pathol 67:113–29.
  • Davis JM, Addison J, Bolton RE, et al. (1986b). The pathogenicity of long versus short fibre samples of amosite asbestos administered to rats by inhalation and intraperitoneal injection. Br J Exp Pathol 67:415–30.
  • Davis JM, Beckett ST, Bolton RE, Donaldson K. (1980). A comparison of the pathological effects in rats of the UICC reference samples of amosite and chrysotile with those of amosite and chrysotile collected from the factory environment. IARC Sci Publ 92:285–92.
  • Davis JM, Beckett ST, Bolton RE, et al. (1978). Mass and number of fibres in the pathogenesis of asbestos-related lung disease in rats. Br J Cancer 37:673–88.
  • Davis JM, Jones AD. (1988). Comparisons of the pathogenicity of long and short fibres of chrysotile asbestos in rats. Br J Exp Pathol 69:717–37.
  • Dement JM, Brown DP, Okun A. (1994). Follow-up study of chrysotile asbestos textile workers: cohort mortality and case-control analyses. Am J Ind Med 26:431–47.
  • Dement JM, Harris RL, Jr., Symons MJ, Shy C. (1982). Estimates of dose–response for respiratory cancer among chrysotile asbestos textile workers. Ann Occup Hyg 26:869–87.
  • Dement JM, Kuempel ED, Zumwalde RD, et al. (2008). Development of a fibre size-specific job-exposure matrix for airborne asbestos fibres. Occup Environ Med 65:605–12.
  • Dement JM, Myers D, Loomis D, et al. (2009). Estimates of historical exposures by phase contrast and transmission electron microscopy in North Carolina USA asbestos textile plants. Occup Environ Med 66:574–83.
  • Dodson RF, Atkinson MA, Levin JL. (2003). Asbestos fiber length as related to potential pathogenicity: a critical review. Am J Ind Med 44:291–7.
  • Dogra S, Donaldson K. (1995). Effect of long and short fibre amosite asbestos on in vitro TNF production by rat alveolar macrophages: the modifying effect of lipopolysaccharide. Ind Health 33:131–41.
  • Doll R, Peto J. (1985). Asbestos: effects on health of exposure to asbestos. London: Her Majesty’s Stationary Office.
  • Donaldson K, Brown GM, Brown DM, et al. (1989). Inflammation generating potential of long and short fibre amosite asbestos samples. Br J Ind Med 46:271–6.
  • Donaldson K, Golyasnya N. (1995). Cytogenetic and pathogenic effects of long and short amosite asbestos. J Pathol 177:303–7.
  • Donaldson K, Miller BG, Sara E, et al. (1993). Asbestos fibre length-dependent detachment injury to alveolar epithelial cells in vitro: role of a fibronectin-binding receptor. Int J Exp Pathol 74:243–50.
  • Donaldson K, Murphy FA, Duffin R, Poland CA. (2010). Asbestos, carbon nanotubes and the pleural mesothelium: a review of the hypothesis regarding the role of long fibre retention in the parietal pleura, inflammation and mesothelioma. Part Fibre Toxicol 7:5.
  • Driscoll KE. (2000). TNFalpha and MIP-2: role in particle-induced inflammation and regulation by oxidative stress. Toxicol Lett 112–113:177–83.
  • ERG. (2003a). Report on the expert panel on health effects of asbestos and synthetic vitreous fibers: the influence of fiber length. Atlanta, GA: Agency for Toxic Substances and Disease Registry, Division of Health Assessment and Consultation.
  • ERG. (2003b). Report on the peer consultation workshop to discuss a proposed protocol to assess asbestos-related risk. Washington, DC: Office of Solid Waste and Emergency Response, U.S. Environmental Protection Agency.
  • Garabrant DH, Alexander DD, Miller PE, et al. (2016). Mesothelioma among motor vehicle mechanics: an updated review and meta-analysis. Ann Occup Hyg 60:8–26.
  • Gibbs GW, Berry G. (2008). Mesothelioma and asbestos. Regul Toxicol Pharmacol 52:S223–S31.
  • Goodglick LA, Kane AB. (1990). Cytotoxicity of long and short crocidolite asbestos fibers in vitro and in vivo. Cancer Res 50:5153–63.
  • Hammad Y, Diem J, Craighead J, Weill H. (1982). Deposition of inhaled man-made mineral fibres in the lungs of rats. Ann Occup Hyg 26:179–87.
  • HEI-AR. (1991). Asbestos in public and commercial buildings: a literature review and synthesis of current knowledge. Cambridge, MA: Health Effects Institute-Asbestos Research.
  • Hesterberg TW, Barrett JC. (1984). Dependence of asbestos- and mineral dust-induced transformation of mammalian cells in culture on fiber dimension. Cancer Res 44:2170–80.
  • Hesterberg TW, Chase G, Axten C, et al. (1998). Biopersistence of synthetic vitreous fibers and amosite asbestos in the rat lung following inhalation. Toxicol Appl Pharmacol 151:262–75. Erratum in: Toxicol Appl Pharmacol 155:292 (1999 Mar 15).
  • Hill IM, Beswick PH, Donaldson K. (1995). Differential release of superoxide anions by macrophages treated with long and short fibre amosite asbestos is a consequence of differential affinity for opsonin. Occup Environ Med 52:92–6.
  • Hodgson JT, Darnton A. (2000). The quantitative risks of mesothelioma and lung cancer in relation to asbestos exposure. Ann Occup Hyg 44:565–601.
  • Hodgson JT, McElvenny DM, Darnton AJ, et al. (2005). The expected burden of mesothelioma mortality in Great Britain from 2002 to 2050. Br J Can 92:587–93.
  • Hughes JM, Weill H. (1986). Asbestos exposure-quantitative assessment of risk. Am Rev Respir Dis 133:5–13.
  • Huncharek M. (1987). Chrysotile asbestos exposure and mesothelioma. Br J Ind Med 44:287–8.
  • Hurbankova M, Kaiglova A. (1997). Some bronchoalveolar lavage parameters and leukocyte cytokine release in response to intratracheal instillation of short and long asbestos and wollastonite fibres in rats. Physiol Res 46:459–66.
  • Ilgren EB. (2002). Coalinga fibre: a short-fibre, amphibole-free chrysotile. Indoor Built Environ 11:171–7.
  • Ilgren E, Chatfield E. (1998a). Coalinga fibre: a short, amphibole-free chrysotile. Part 2: evidence for lack of tumourigenic activity. Indoor Built Environ 7:18–31.
  • Ilgren E, Chatfield E. (1998b). Coalinga fibre: a short, amphibole-free chrysotile: Part 3: lack of biopersistence. Indoor Built Environ 7:98–109.
  • Ilgren E, Chatfield E. (1997). Coalinga fibre: a short, amphibolic-free chrysotile. Part 1: evidence for lack of fibrogenic activity. Indoor Built Environ 6:264–76.
  • Jaurand MC, Bignon J, Sebastien P, Goni J. (1977). Leaching of chrysotile asbestos in human lungs. Correlation with in vitro studies using rabbit alveolar macrophages. Environ Res 14:245–54.
  • Kaw JL, Tilkes F, Beck EG. (1982). Reaction of cells cultured in vitro to different asbestos dusts of equal surface area but different fibre length. Br J Exp Pathol 63:109–15.
  • King EJ, Clegg JW, Rae VM. (1946). The effect of asbestos, and of asbestos and aluminium, on the lungs of rabbits. Thorax 1:188–97.
  • Kuschner M, Wright G. (1976). The effects of intratracheal instillation of glass fiber of varying sizes in guinea pigs. In: NIOSH (ed.) Occupational Exposure to Fibrous Glass: Proceedings of a Symposium; 1976 Apr. Washington, DC: U.S. Dept. of Health, Education, and Welfare, Public Health Service, Center for Disease Control, National Institute for Occupational Safety and Health, 151–68.
  • Laden F, Stampfer MJ, Walker AM. (2004). Lung cancer and mesothelioma among male automobile mechanics: a review. Rev Environ Health 19:39–61.
  • Langer AM, Nolan RP. (1994). Chrysotile biopersistence in the lungs of persons in the general population and exposed workers. Environ Health Perspect 102(Suppl. 5): 235–9.
  • Lemaire I, Nadeau D, Dunnigan J, Masse S. (1985). An assessment of the fibrogenic potential of very short 4T30 chrysotile by intratracheal instillation in rats. Environ Res 36:314–26.
  • Lippmann M. (1988). Asbestos exposure indices. Environ Res 46:86–106.
  • Lippmann M. (1994). Deposition and retention of inhaled fibres: effects on incidence of lung cancer and mesothelioma. Occup Environ Med 51:793–8.
  • Loomis D, Dement JM, Elliott L, et al. (2012). Increased lung cancer mortality among chrysotile asbestos textile workers is more strongly associated with exposure to long thin fibres. Occup Environ Med 69:564–8.
  • Mann EL. (1983). Asbestos. In: Lefond SJ (ed) Industrial minerals and rocks. 5th ed. New York: Society Mining Engineers of the American Institute of Mining, Metallurgical, and Petroleum Engineers, 435–84.
  • Marsh JP, Mossman BT. (1988). Mechanisms of induction of ornithine decarboxylase activity in tracheal epithelial cells by asbestiform minerals. Cancer Res 48:709–14.
  • McDonald AD, Fry JS, Woolley AJ, McDonald J. (1983a). Dust exposure and mortality in an American chrysotile textile plant. Br J Ind Med 40:361–7.
  • McDonald AD, Fry JS, Woolley AJ, McDonald JC. (1983b). Dust exposure and mortality in an American factory using chrysotile, amosite, and crocidolite in mainly textile manufacture. Br J Ind Med 40:368–74.
  • Meldrum M. (1996). Review of fibre toxicology. Sudbury: HSE Books, HMSO.
  • Miller BG, Jones AD, Searl A, et al. (1999). Influence of characteristics of inhaled fibres on development of tumours in the rat lung. Ann Occup Hyg 43:167–79.
  • Morgan A. (1995). Deposition of inhaled asbestos and man-made mineral fibres in the respiratory tract. Ann Occup Hyg 39:747–58.
  • Morgan A, Black A, Evans N, et al. (1980). Deposition of sized glass fibres in the respiratory tract of the rat. Ann Occup Hyg 23:353–66.
  • Morgan A, Talbot RJ, Holmes A. (1978). Significance of fibre length in the clearance of asbestos fibres from the lung. Br J Ind Med 35:146–53.
  • Mossman BT, Lippmann M, Hesterberg TW, et al. (2011). Pulmonary endpoints (lung carcinomas and asbestosis) following inhalation exposure to asbestos. J Toxicol Environ Health B Crit Rev 14:76–121.
  • Murphy FA, Poland CA, Duffin R, et al. (2011). Length-dependent retention of carbon nanotubes in the pleural space of mice initiates sustained inflammation and progressive fibrosis on the parietal pleura. Am J Pathol 178:2587–600.
  • Nicholson WJ. (1991). Comparative dose–response relationship of asbestos fiber types: magnitudes and uncertainties. Ann NY Acad Sci 643:74–84.
  • Nicholson WJ, Landrigan PJ. (1994). The carcinogenicity of chrysotile asbestos. Advances in modern environmental toxicology (volume 22): the identification and control of environmental and occupational diseases: asbestos and cancer. Princeton, NJ: Princeton Scientific Publishing Co., 407–23.
  • Nicholson WJ, Landrigan PJ. (1996). Asbestos: a status report. Curr Issues Public Health 2:118–23.
  • Nicholson WJ, Raffn E. (1995). Recent data on cancer due to asbestos in the USA and Denmark. Med Lav 86:393–410.
  • Nicholson WJ. (2001). The carcinogenicity of chrysotile asbestos—a review. Ind Health 39:57–64.
  • Oberdorster G. (1995). Lung particle overload: implications for occupational exposures to particles. Regul Toxicol Pharmacol 27:123–35.
  • Osmond-McLeod MJ, Poland CA, Murphy F, et al. (2011). Durability and inflammogenic impact of carbon nanotubes compared with asbestos fibres. Part Fibre Toxicol 8:15.
  • Pierce JS, Ruestow PS, Finley BL. (2016). An updated evaluation of reported no-observed adverse effect levels for chrysotile asbestos for lung cancer and mesothelioma. Crit Rev Toxicol 46:561–86.
  • Pigg BJ. (1994). The uses of chrysotile. Ann Occup Hyg 38:453–8.
  • Platek SF, Groth DH, Ulrich CE, et al. (1985). Chronic inhalation of short asbestos fibers. Fundam App Toxicol 5:327–40.
  • Pott F. (1978). Some aspects on the dosimetry of the carcinogenic potency of asbestos and other fibrous dusts. Straub-Reinhalt Luft 38:486–90.
  • Pott F, Friedrichs KH, Huth F. (1976). Results of animal experiments concerning the carcinogenic effect of fibrous dusts and their interpretation with regard to the carcinogenesis in humans (author's transl). Zentralbl Bakteriol Orig B 162:467–505.
  • Pott F, Huth F, Friedrichs KH. (1972). Tumors of rats after i.p. injection of powdered chrysotile and benzo(a)pyrene. Zentralbl Bakteriol Orig B 155:463–9.
  • Pott F, Huth F, Friedrichs KH. (1974). Tumorigenic effect of fibrous dusts in experimental animals. Environ Health Perspect 9:313–5.
  • Riganti C, Aldieri E, Bergandi L, et al. (2003). Long and short fiber amosite asbestos alters at a different extent the redox metabolism in human lung epithelial cells. Toxicol Appl Pharmacol 193:106–15.
  • Rittinghausen S, Ernst H, Muhle H, et al. (1991). Histopathological analysis of tumour types after intraperitoneal injections of mineral fibres in rats. In: Brown, RC, Hoskins, JA, Johnson, NF (eds.) Mechanisms in fibre carcinogenesis. Albuquerque: NATO ASI Series, 81–9.
  • Roggli VL, Brody AR. (1984). Changes in numbers and dimensions of chrysotile asbestos fibers in lungs of rats following short-term exposure. Exp Lung Res 7:133–47.
  • Searl A, Buchanan D, Cullen RT, et al. (1999). Biopersistence and durability of nine mineral fibre types in rat lungs over 12 months. Ann Occup Hyg 43:143–53.
  • Smith JM, Wootton ID, King EJ. (1951). Experimental asbestosis in rats. The effect of particle size and of added alumina. Thorax 6:127–36.
  • Snipes MB. (1995). Pulmonary retention of particles and fibres: biokinetics and effects of exposure concentrations. In: MacClellan RO, Henderson RF (eds.) Concepts in inhalation toxicology. 2nd ed. Washington, DC: Taylor & Francis, 225–55.
  • Stanton MF. (1973). Some etiological considerations of fibre carcinogenesis. In: Bogovski P, Timbrell V, Gilson JC, Wagner JC (eds.) Biological Effects of Asbestos: Proceedings of a Working Conference. IARC Scientific Publications No. 8. Lyon: International Agency for Research on Cancer, 289–94.
  • Stanton MF, Layard M, Tegeris A, et al. (1977). Carcinogenicity of fibrous glass: pleural response in the rat in relation to fiber dimension. J Natl Cancer Inst 58:587–603.
  • Stanton MF, Layard M, Tegeris A, et al. (1981). Relation of particle dimension to carcinogenicity in amphibole asbestoses and other fibrous minerals. J Natl Cancer Inst 67:965–75.
  • Stanton MF, Wrench C. (1972). Mechanisms of mesothelioma induction with asbestos and fibrous glass. J Natl Cancer Inst 48:797–821.
  • Stettler LE, Sharpnack DD, Krieg EF. (2008). Chronic inhalation of short asbestos: lung fiber burdens and histopathology for monkeys maintained for 11.5 years after exposure. Inhal Toxicol 20:63–73.
  • Suzuki Y, Yuen SR. (2001). Asbestos tissue burden study on human malignant mesothelioma. Ind Health 39:150–60.
  • Suzuki Y, Yuen SR. (2002). Asbestos fibers contributing to the induction of human malignant mesothelioma. Ann NY Acad Sci 982:160–76.
  • Suzuki Y, Yuen SR, Ashley R. (2005). Short, thin asbestos fibers contribute to the development of human malignant mesothelioma: pathological evidence. Int J Hyg Environ Health 208:201–10.
  • Tilkes F, Beck EG. (1980). Comparison of length-dependent cytotoxicity of inhalable asbestos and man-made mineral fibres. IARC Sci Publ 30:475–83.
  • Tilkes F, Beck EG. (1983). Macrophage functions after exposure to mineral fibers. Environ Health Perspect 51:67–72.
  • Timbrell V. (1965). Human exposure to asbestos: dust controls and standards. The inhalation of fibrous dusts. Ann N Y Acad Sci 132:255–73.
  • Timbrell V, Bevan NE, Davies AS, Munday DE. (1970). Hollow casts of lungs for experimental purposes. Nature 225:97–8.
  • Tossavainen A, Karjalainen A, Karhunen PJ. (1994). Retention of asbestos fibers in the human body. Environ Health Perspect 102(Suppl. 5):253–5.
  • Vorwald AJ, Durkan TM, Pratt PC. (1951). Experimental studies of asbestosis. AMA Arch Ind Hyg Occup Med 3:1–43.
  • Wagner JC. (1990). Biological effects of short fibers. Proceedings of the VIIth International Pneumoconiosis Conference Part II, November. DHHS (NIOSH) Publication No. 90-108 Part II. Animal Models-Pneumoconiosis II; 1990 Nov. Washington, DC: U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control, National Institute for Occupational Safety and Health, 835–9.
  • Wagner JC, Berry G, Skidmore JW, Pooley FD. (1980). The comparative effects of three chrysotiles by injection and inhalation in rats. IARC Sci Publ 92:363–72.
  • Wagner JC, Berry G, Skidmore JW, Timbrell V. (1974). The effects of the inhalation of asbestos in rats. Br J Cancer 29:252–69.
  • Wagner JC, Griffiths DM, Hill RJ. (1984). The effect of fibre size on the in vivo activity of UICC crocidolite. Br J Cancer 49:453–8.
  • Wagner JC, Skidmore JW, Hill RJ, Griffiths DM. (1985). Erionite exposure and mesotheliomas in rats. Br J Cancer 51:727–30.
  • Webster I. (1970). The pathogenesis of asbestosis. In: Shapiro HA (ed.) Pneumoconiosis: Proceedings of the International Conference. Johannesburg, 1969. Cape Town: Oxford University Press, 117–9.
  • Woodworth CD, Mossman BT, Craighead JE. (1983). Induction of squamous metaplasia in organ cultures of hamster trachea by naturally occurring and synthetic fibers. Cancer Res 43:4906–12.
  • Wright GW, Kuschner M. (1975). The influence of varying lengths of glass and asbestos fibres on tissue response in guinea pigs. Inhaled Part 4 Pt 2:455–74.
  • Yeager H, Jr., Russo DA, Yanez M, et al. (1983). Cytotoxicity of a short-fiber chrysotile asbestos for human alveolar macrophages: preliminary observations. Environ Res 30:224–32.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.